(Q36425853)

14 August 2017

0 references

Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy (English)

1 reference

14 August 2017

0 references

1 reference

5

Henrik Zetterberg

1 reference

14 August 2017

2

Dietmar Fuchs

1 reference

14 August 2017

3

Lars Hagberg

1 reference

14 August 2017

4

Bo Svennerholm

1 reference

14 August 2017

Magnus Gisslén

1

1 reference

14 August 2017

9 July 2012

1 reference

14 August 2017

1 reference

14 August 2017

44

1 reference

14 August 2017

12

1 reference

14 August 2017

997-1000

1 reference

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

Elevated neurofilament levels in neurological diseases.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

Cost-efficacy analysis of the MONET trial using UK antiretroviral drug prices

28 June 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.690526

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.690526

Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.690526

The role of compartment penetration in PI-Monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.690526

Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 September 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.690526

96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.690526

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3507278

Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22776013

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22776013

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3109/00365548.2012.690526

1 reference

14 August 2017

1 reference

PMC publication ID

3507278

14 August 2017

PubMed publication ID

22776013

1 reference

PMC publication ID

3507278